Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously announced by Exelixis, Inc. ("Exelixis"), effective June 18, 2021,
Gisela M. Schwab, M.D., President, Product Development and Medical Affairs and
Chief Medical Officer of Exelixis, began a medical leave of absence. Dr. Schwab
will remain available to advise Exelixis as needed during her medical leave of
absence.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses